Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa
Authors
Keywords
Rifampin, Apixaban, Breast Cancer Resistance Protein, Absolute Oral Bioavailability, Single Ascend Dose Study
Journal
American Journal of Cardiovascular Drugs
Volume 16, Issue 2, Pages 119-127
Publisher
Springer Nature
Online
2016-01-09
DOI
10.1007/s40256-015-0157-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
- (2015) Charles E. Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Age and Sex on the Single-Dose Pharmacokinetics and Pharmacodynamics of Apixaban
- (2015) Charles E. Frost et al. CLINICAL PHARMACOKINETICS
- LC–MS/MS determination of apixaban (BMS-562247) and its major metabolite in human plasma: an application of polarity switching and monolithic HPLC column
- (2014) Janice Pursley et al. Bioanalysis
- Effect of Activated Charcoal on Apixaban Pharmacokinetics in Healthy Subjects
- (2013) Xiaoli Wang et al. American Journal of Cardiovascular Drugs
- Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects
- (2013) Charles Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects
- (2012) Charles Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor
- (2011) Kan He et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tissue Distribution and Elimination of [14C]Apixaban in Rats
- (2010) L. Wang et al. DRUG METABOLISM AND DISPOSITION
- Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
- (2010) Michael Rud Lassen et al. LANCET
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement
- (2010) Michael Rud Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sulfation of O-Demethyl Apixaban: Enzyme Identification and Species Comparison
- (2009) L. Wang et al. DRUG METABOLISM AND DISPOSITION
- Comparative Metabolism of 14C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans
- (2009) D. Zhang et al. DRUG METABOLISM AND DISPOSITION
- In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies
- (2009) L. Wang et al. DRUG METABOLISM AND DISPOSITION
- Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement
- (2009) Michael Rud Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping
- (2008) Bettina Link et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
- (2008) N. Raghavan et al. DRUG METABOLISM AND DISPOSITION
- Apixaban, an oral, direct and highly selective factor Xa inhibitor:in vitro, antithrombotic and antihemostatic studies
- (2008) P. C. WONG et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started